Blocking the hedgehog pathway inhibits hepatoblastoma growth - PubMed (original) (raw)
Blocking the hedgehog pathway inhibits hepatoblastoma growth
Melanie Eichenmüller et al. Hepatology. 2009 Feb.
Abstract
Recent evidence has indicated that Hedgehog (Hh) signaling significantly contributes to liver development and regeneration and that activation of the pathway may contribute to growth of hepatocellular carcinoma (HCC) in adults. However, the role of Hh signaling in pediatric liver tumors remains to be elucidated. In this study, we show that Hh signaling is activated in hepatoblastoma (HB), the most common liver tumor in childhood, with most occurrences before the age of 3 years. The Hh target genes glioma-associated oncogene homolog 1 (GLI1) and Patched (PTCH1) showed increased transcript levels in 65% and 30% of HB samples, respectively, compared with normal liver tissues. Most interestingly, the gene encoding the hedgehog interacting protein (HHIP) is transcriptionally silenced by cytosine-phospho-guanosine (CpG) island promoter hypermethylation in 26% of HB cases and treatment with the DNA-demethylating agent 5-aza-2'-deoxycytidine partially restored HHIP expression. Blocking Hh signaling with the antagonist cyclopamine had a strong inhibitory effect on cell proliferation of HB cell lines with an activated pathway. We further demonstrate that this decrease in cell viability is caused by a massive induction of apoptosis, as shown by morphological changes and phosphatidylserine membrane asymmetry. In cyclopamine-exposed HB cells, caspase 3 and poly(adenosine diphosphate-ribose) polymerase proteins were specifically activated by their proteolytic cleavage.
Conclusion: This study demonstrates, for the first time, the frequent occurrence of GLI1 and PTCH1 overexpression and HHIP promoter methylation in early childhood HB, thus indicating a key role for Hh signaling activation in the malignant transformation of embryonal liver cells.
Similar articles
- Down-regulation of hedgehog-interacting protein through genetic and epigenetic alterations in human hepatocellular carcinoma.
Tada M, Kanai F, Tanaka Y, Tateishi K, Ohta M, Asaoka Y, Seto M, Muroyama R, Fukai K, Imazeki F, Kawabe T, Yokosuka O, Omata M. Tada M, et al. Clin Cancer Res. 2008 Jun 15;14(12):3768-76. doi: 10.1158/1078-0432.CCR-07-1181. Clin Cancer Res. 2008. PMID: 18559595 - Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H, Yamamoto H, Akutsu N, Nosho K, Adachi Y, Imai K, Shinomura Y. Taniguchi H, et al. J Pathol. 2007 Oct;213(2):131-9. doi: 10.1002/path.2216. J Pathol. 2007. PMID: 17724792 - Betulinic acid treatment promotes apoptosis in hepatoblastoma cells.
Eichenmüller M, von Schweinitz D, Kappler R. Eichenmüller M, et al. Int J Oncol. 2009 Oct;35(4):873-9. doi: 10.3892/ijo_00000402. Int J Oncol. 2009. PMID: 19724925 - Role of the Hedgehog pathway in hepatocellular carcinoma (review).
Zheng X, Zeng W, Gai X, Xu Q, Li C, Liang Z, Tuo H, Liu Q. Zheng X, et al. Oncol Rep. 2013 Nov;30(5):2020-6. doi: 10.3892/or.2013.2690. Epub 2013 Aug 22. Oncol Rep. 2013. PMID: 23970376 Review. - DNA methylation in Hepatoblastoma-a literature review.
Shen G, Shen H, Zhang J, Yan Q, Liu H. Shen G, et al. Ital J Pediatr. 2020 Aug 5;46(1):113. doi: 10.1186/s13052-020-00877-6. Ital J Pediatr. 2020. PMID: 32758256 Free PMC article. Review.
Cited by
- Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma.
Beck A, Trippel F, Wagner A, Joppien S, Felle M, Vokuhl C, Schwarzmayr T, Strom TM, von Schweinitz D, Längst G, Kappler R. Beck A, et al. Clin Epigenetics. 2018 Mar 2;10:27. doi: 10.1186/s13148-018-0462-7. eCollection 2018. Clin Epigenetics. 2018. PMID: 29507645 Free PMC article. - Downregulation of hedgehog-interacting protein (HHIP) contributes to hexavalent chromium-induced malignant transformation of human bronchial epithelial cells.
Li P, Zhang X, Murphy AJ, Costa M, Zhao X, Sun H. Li P, et al. Carcinogenesis. 2021 Feb 11;42(1):136-147. doi: 10.1093/carcin/bgaa085. Carcinogenesis. 2021. PMID: 32710611 Free PMC article. - Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma.
Lv D, Chen L, Du L, Zhou L, Tang H. Lv D, et al. Front Cell Dev Biol. 2021 Jul 22;9:691410. doi: 10.3389/fcell.2021.691410. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34368140 Free PMC article. Review. - Avatars to personalized medicine: of mice and men.
Ilmer M, Berger M. Ilmer M, et al. Hepatobiliary Surg Nutr. 2017 Oct;6(5):347-349. doi: 10.21037/hbsn.2017.06.05. Hepatobiliary Surg Nutr. 2017. PMID: 29152486 Free PMC article. No abstract available. - Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma.
Gödeke J, Luxenburger E, Trippel F, Becker K, Häberle B, Müller-Höcker J, von Schweinitz D, Kappler R. Gödeke J, et al. Hepatol Int. 2016 Mar;10(2):370-6. doi: 10.1007/s12072-015-9686-1. Epub 2015 Dec 8. Hepatol Int. 2016. PMID: 26646663
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials